3 - Epidemiology and Public Health Flashcards

1
Q

Provide the highest level of proof of an effect by minimizing bias

A

Internal validity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Generalizability

A

External validity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Attribute that increases the likelihood of developing a disease

A

Risk factor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Occurs when an attribute or other factor is found to be related to an outcome of interest

A

Association

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Systematic error that causes the results of a study to deviate from the truth

A

Bias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Ultimate problem with bias

A

Can’t be measured

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Occurs when two risk factors or exposures are associated with each other and the outcome of interest

A

Confounding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Measure of an effect in an ideal setting

A

Efficacy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

If the study was repeated using the same study design and the same cohort, the same results would be found

A

Internally valid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Studies that measure efficacy

A

Explanatory studies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How well an intervention works in the real world

A

Effectiveness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Studies that compare two or more treatments that are generally accepted to be effective

A

Comparative effectiveness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Studies that lack the regulatory oversight that is required by federal agencies when treatments receive initial approval

A

Pragmatic studies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

First studies performed in humans

A

Phase I studies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Evaluate a drug’s dose, range, safety, tolerability, pharmacokinetics, and pharmacodynamics

A

Phase I studies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Also called initial efficacy studies

A

Phase II studies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Determine the effect of an intervention in patients with the disease of interest

A

Phase II studies

18
Q

Also called comparative efficacy studies

A

Phase III studies

19
Q

Assess the efficacy of an intervention compared with that of a “control” treatment

A

Phase III studies

20
Q

Sometimes called, pivotal studies, provide the data necessary for regulatory agencies to decide whether or not to approve a dug

A

Phase III studies

21
Q

Also called postmarketing studies or effectiveness studies

A

Phase IV studies

22
Q

Also known as large sample studies or Peto studies

A

Pragmatic trials

23
Q

Effectiveness studies that focus on understanding how an intervention works in the routine clinical setting

A

Pragmatic trials

24
Q

Cohort vs case-control study

A

Cohort: prospective

Case-control: retrospective

25
Q

Meta-analytic technique that enables comparisons between treatments that were never directly compare in individual studies

A

Network of evidence or mixed treatment comparison

26
Q

Frequency of a disease or other outcome of interest over a given period of time

A

Prevalence

27
Q

Number of individuals with a disease divided by the number of individuals sampled over a specified time period

A

Prevalence

28
Q

Frequency of new cases of a disease or other outcome anong those who are at risk of the disease or outcome of interest within a specified period of time

A

Incidence

29
Q

Dividing the number of individuals who developed sa disease by the number of individuals in the at-risk population

A

Incidence

30
Q

Ratio of how an outcome is measured in those with a disease versus those without a disease

A

Risk ratio or relative risk or hazard ratio

31
Q

Absolute risk in the exposed persons minus the absolute risk in the nonexposed persons

A

Attributable risk or risk difference

32
Q

Ratio of the odds that a case is exposed compared with the odds that a control is exposed

A

Odds ratio

33
Q

Relationship of odds ratios and relative risk when the outcome is rare

A

Equivalent

34
Q

Relationship of odds ratios and relative risk when the outcome is common

A

Odds ratio overestimates the relative risk

35
Q

Proportion of truly diseased individuals who are defined as having disease by a test

A

Sensitivity

36
Q

Also called true positive rate

A

Sensitivity

37
Q

Proportion of individuals who truly do not have the disease who are defined by the test as not having the disease

A

Specificity

38
Q

Also called true negative rate

A

Specificity

39
Q

Proportion of individuals who have a positive test that truly have the disease

A

Positive predictive value

40
Q

Proportion of individuals who have a negative test that truly do not have the disease

A

Negative predictive value